1Schult Z, Sartor B. Probiotics and in inflammatory bowel disease.AM J Gastroenterol,2000,95(supple) :S19-S21.
2Sands BE. Novel therapies for inflammatory bowel disease. Gastroenterol Clin North Am, 1999,282: 334-335,338,340.
3Albert LM, Patel J, Ferranti TJ, et al. Soluble recombinant human P selectin glycoprotein ligand-1 (SPSGL-1) diseases intestinallesions in HLA-B27 transgenic rats and in acetic acid-incluced colitisin Sprague-Dawley rats. Gastroenterology, 1998,114 :A918.
4Sc B, Han PD, Burke A, et al. Nutrition and inflammatory boweldisease. Gastroenterol Clin North Am, 1999,28:433.
5Hawkey CF, Snowden FA, Lobo A, et al. Stem cell transplantation for inflammatory bowel disease: practical and ethical issue.Gut, 2000,46: 869.
6Korzenik JR, Dieckgraefe T. Is Crohn's disease an immunodeficiency A hypothesis suggesting possible early events in the pathogenesis of Crohn disease. Dig Dis Sci, 2000,45:1121.
7Green JT, Rhodes J, Ragunath K, et al. Clinical status of ulcerative colitis in patients who smoke. Am J Gastroenterol, 1998,93:1463.
8Hilsden K J, Hodgins DC, Timmer AT, et al. Helping patientswith Crohn' s quit smoking. Am J Gastroenterology,2000,95:352.
9Jones NL, Roifman CM, Griffiths AM, et al. Ketotifen therapyfor acute ulcerative colitis in children: A pilot study. Dig Dis Sci,1998,43: 609.
10Ayabe T, Ashida T, Taniguchi M, et al. A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerativecolitis. Intern Med, 1997,36: 322.
